504 related articles for article (PubMed ID: 27432743)
21. Effect of alanine supplementation on oxalate synthesis.
Wood KD; Freeman BL; Killian ME; Lai WS; Assimos D; Knight J; Fargue S
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165981. PubMed ID: 33002578
[TBL] [Abstract][Full Text] [Related]
22. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria.
Marangella M; Petrarulo M; Cosseddu D; Vitale C; Linari F
Am J Kidney Dis; 1992 Jun; 19(6):546-53. PubMed ID: 1595703
[TBL] [Abstract][Full Text] [Related]
23. Lumasiran: A Review in Primary Hyperoxaluria Type 1.
Kang C
Drugs; 2024 Feb; 84(2):219-226. PubMed ID: 38252335
[TBL] [Abstract][Full Text] [Related]
24. Hyperoxaluria, hyperglycoluria and renal oxalosis in Gilbert's potoroos (Potorous gilbertii).
Forshaw D; Horwitz AM; Ellard K; Friend JA; Greed L; Metz M
Aust Vet J; 2017 Jul; 95(7):250-258. PubMed ID: 28653383
[TBL] [Abstract][Full Text] [Related]
25. Improving Treatment Options for Primary Hyperoxaluria.
Hoppe B; Martin-Higueras C
Drugs; 2022 Jul; 82(10):1077-1094. PubMed ID: 35779234
[TBL] [Abstract][Full Text] [Related]
26. Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure.
Raju DL; Cantarovich M; Brisson ML; Tchervenkov J; Lipman ML
Am J Kidney Dis; 2008 Jan; 51(1):e1-5. PubMed ID: 18155525
[TBL] [Abstract][Full Text] [Related]
27. Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria.
Clifford-Mobley O; Rumsby G; Kanodia S; Didi M; Holt R; Senniappan S
Pediatr Nephrol; 2017 Nov; 32(11):2159-2163. PubMed ID: 28752386
[TBL] [Abstract][Full Text] [Related]
28. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
Chetyrkin SV; Kim D; Belmont JM; Scheinman JI; Hudson BG; Voziyan PA
Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227
[TBL] [Abstract][Full Text] [Related]
29. Primary hyperoxaluria type 1 in Japan.
Ichiyama A; Oda T; Maeda-Nakai E
Cell Biochem Biophys; 2000; 32 Spring():171-6. PubMed ID: 11330044
[TBL] [Abstract][Full Text] [Related]
30. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.
Garrelfs SF; van Harskamp D; Peters-Sengers H; van den Akker CHP; Wanders RJA; Wijburg FA; van Goudoever JB; Groothoff JW; Schierbeek H; Oosterveld MJS
J Am Soc Nephrol; 2021 Dec; 32(12):3175-3186. PubMed ID: 34686543
[TBL] [Abstract][Full Text] [Related]
31. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
Hatch M; Gjymishka A; Salido EC; Allison MJ; Freel RW
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G461-9. PubMed ID: 21163900
[TBL] [Abstract][Full Text] [Related]
32. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
[TBL] [Abstract][Full Text] [Related]
33. Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity.
Wood KD; Holmes RP; Erbe D; Liebow A; Fargue S; Knight J
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2203-2209. PubMed ID: 31055082
[TBL] [Abstract][Full Text] [Related]
34. Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
Scheinman JI; Voziyan PA; Belmont JM; Chetyrkin SV; Kim D; Hudson BG
Urol Res; 2005 Nov; 33(5):368-71. PubMed ID: 16292584
[TBL] [Abstract][Full Text] [Related]
35. Primary hyperoxaluria type 1: still challenging!
Cochat P; Liutkus A; Fargue S; Basmaison O; Ranchin B; Rolland MO
Pediatr Nephrol; 2006 Aug; 21(8):1075-81. PubMed ID: 16810517
[TBL] [Abstract][Full Text] [Related]
36. Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
Martin-Higueras C; Ludwig-Portugall I; Hoppe B; Kurts C
Nephrol Dial Transplant; 2019 Jun; 34(6):908-914. PubMed ID: 30169827
[TBL] [Abstract][Full Text] [Related]
37. Primary hyperoxaluria type 1: pathophysiology and genetics.
Fargue S; Acquaviva Bourdain C
Clin Kidney J; 2022 May; 15(Suppl 1):i4-i8. PubMed ID: 35592619
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of liver and kidney proteins in a mouse model for primary hyperoxaluria type I.
Hernández-Fernaud JR; Salido E
FEBS J; 2010 Nov; 277(22):4766-74. PubMed ID: 20977670
[TBL] [Abstract][Full Text] [Related]
39. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
Monico CG; Persson M; Ford GC; Rumsby G; Milliner DS
Kidney Int; 2002 Aug; 62(2):392-400. PubMed ID: 12110000
[TBL] [Abstract][Full Text] [Related]
40. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats.
Zheng R; Fang X; He L; Shao Y; Guo N; Wang L; Liu M; Li D; Geng H
Curr Mol Med; 2018; 18(7):436-447. PubMed ID: 30539697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
